Clinical Trial Update: An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

An update on Phase 1/2 trials evaluating nivolumab, alone or in combination with other agents, for advanced hepatocellular carcinoma, with the study listed as c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-12-24